Statistics
Publications
12
Citations
2.5K
H-Index
12
Active since
2017
Tu Van Dao is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and durvalumab therapy.
Publications per year
2017–2025
12
12
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo et al. · NEJM Evidence · 2022 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Ghassan K. Abou‐Alfa, Stephen L. Chan, Masatoshi Kudo et al. · Journal of Clinical Oncology · 2022 · 400 citations
Pharmacy, Oncology, Pharmacotherapy +17
Jonathan E. Rosenberg, Se Hoon Park, Vadim Kozlov et al. · Journal of Clinical Oncology · 2022 · 51 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 12